Literature DB >> 15832445

Non-Michaelis-Menten kinetics in cytochrome P450-catalyzed reactions.

William M Atkins1.   

Abstract

The cytochrome P450 monooxygenases (CYPs) are the dominant enzyme system responsible for xenobiotic detoxification and drug metabolism. Several CYP isoforms exhibit non-Michaelis-Menten, or "atypical," steady state kinetic patterns. The allosteric kinetics confound prediction of drug metabolism and drug-drug interactions, and they challenge the theoretical paradigms of allosterism. Both homotropic and heterotropic ligand effects are now widely documented. It is becoming apparent that multiple ligands can simultaneously bind within the active sites of individual CYPs, and the kinetic parameters change with ligand occupancy. In fact, the functional effect of any specific ligand as an activator or inhibitor can be substrate dependent. Divergent approaches, including kinetic modeling and X-ray crystallography, are providing new information about how multiple ligand binding yields complex CYP kinetics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15832445     DOI: 10.1146/annurev.pharmtox.45.120403.100004

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  69 in total

1.  Multiple ligand docking by Glide: implications for virtual second-site screening.

Authors:  Márton Vass; Ákos Tarcsay; György M Keserű
Journal:  J Comput Aided Mol Des       Date:  2012-05-26       Impact factor: 3.686

2.  Allosteric activation of cytochrome P450 3A4 by α-naphthoflavone: branch point regulation revealed by isotope dilution analysis.

Authors:  Caleb M Woods; Cristina Fernandez; Kent L Kunze; William M Atkins
Journal:  Biochemistry       Date:  2011-10-28       Impact factor: 3.162

3.  Hybrid homology modeling and mutational analysis of cytochrome P450C24A1 (CYP24A1) of the Vitamin D pathway: insights into substrate specificity and membrane bound structure-function.

Authors:  Andrew J Annalora; Ekaterina Bobrovnikov-Marjon; Rita Serda; Andrzej Pastuszyn; Sandra E Graham; Craig B Marcus; John L Omdahl
Journal:  Arch Biochem Biophys       Date:  2006-12-03       Impact factor: 4.013

4.  Inhibition of recombinant cytochrome P450 isoforms 2D6 and 2C9 by diverse drug-like molecules.

Authors:  Daniel R McMasters; Rhonda A Torres; Susan J Crathern; Deborah L Dooney; Robert B Nachbar; Robert P Sheridan; Kenneth R Korzekwa
Journal:  J Med Chem       Date:  2007-06-09       Impact factor: 7.446

5.  Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4.

Authors:  Abhinav Nath; Cristina Fernández; Jed N Lampe; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2008-03-25       Impact factor: 4.013

6.  Mixing apples and oranges: Analysis of heterotropic cooperativity in cytochrome P450 3A4.

Authors:  Daniel J Frank; Ilia G Denisov; Stephen G Sligar
Journal:  Arch Biochem Biophys       Date:  2009-06-26       Impact factor: 4.013

7.  Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection.

Authors:  Santosh Kumar; Huan Qiu; Numan Oezguen; Holger Herlyn; James R Halpert; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2009-03-19       Impact factor: 3.922

8.  Ligand-induced conformational heterogeneity of cytochrome P450 CYP119 identified by 2D NMR spectroscopy with the unnatural amino acid (13)C-p-methoxyphenylalanine.

Authors:  Jed N Lampe; Stephen N Floor; John D Gross; Clinton R Nishida; Yongying Jiang; Michael J Trnka; Paul R Ortiz de Montellano
Journal:  J Am Chem Soc       Date:  2008-12-03       Impact factor: 15.419

9.  Conformational selection is present in ligand binding to cytochrome P450 19A1 lipoprotein nanodiscs.

Authors:  Francisco Zárate-Pérez; John C Hackett
Journal:  J Inorg Biochem       Date:  2020-05-21       Impact factor: 4.155

10.  Cooperative effects on radical recombination in CYP3A4-catalyzed oxidation of the radical clock beta-thujone.

Authors:  Yongying Jiang; Paul R Ortiz de Montellano
Journal:  Chembiochem       Date:  2009-03-02       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.